What is IonDX?
IonDX is a bioanalytical instrumentation company at the forefront of macromolecule ion mobility technology. Their advanced analytical solutions are designed to characterize complex biopharmaceuticals, biosimilars, and polymers, including critical biologic drugs like glycoproteins, CRISPR-Cas, mRNA, and lipid nanoparticles. The company's patented ion mobility technology is engineered for compact, benchtop use, offering versatility across diverse laboratory settings. IonDX's mission is to elevate ion mobility intelligence for the life sciences research and development sector, providing researchers with enhanced analytical capabilities.
How much funding has IonDX raised?
IonDX has raised a total of $55K across 1 funding round:
Debt
$55K
Debt (2021): $55K with participation from PPP
What's next for IonDX?
With the recent infusion of substantial expansion capital, IonDX is poised for accelerated growth and further innovation. The company's strategic focus will likely involve scaling its manufacturing capabilities, expanding its sales and marketing reach, and continuing its research and development efforts to enhance its disruptive ion mobility technology. This latest funding round, occurring at a significant Series B/C stage, suggests a strong trajectory towards market leadership in the bioanalytical instrumentation space, enabling broader adoption of its advanced characterization tools for biopharmaceutical development and quality control.
See full IonDX company page
